Interleukin-13 Antagonist drugs

2 medications in the FDA established pharmacologic class “Interleukin-13 Antagonist”.

DrugTypeNDC products
Adbry
Tralokinumab-ldrm		Rx2
Ebglyss
Lebrikizumab-lbkz		Rx2